Friday, March 1, 2024
- Advertisement -spot_img

TAG

BioLineRx Ltd.

BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate and Portfolio Updates

- Received FDA Approval of APHEXDA® (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in...

Latest news

- Advertisement -spot_img